Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib plus Letrozole in HER2-negative Breast Cancer
NCT00422903Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2007
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by GSK. Started Apr 2007; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00422903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00422903.